Search

everythinglearnresearchcommunity

for

Search:↓

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

FFA's causes may include environmental triggers and genetic factors.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Some psychiatric medications can cause hair loss, but it usually grows back after adjusting the medication.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Non-immune factors play a significant role in alopecia areata.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.